Overview

Towards Neurobiology-based Diagnosis and Treatment of Affective Disorders

Status:
Recruiting
Trial end date:
2022-08-01
Target enrollment:
Participant gender:
Summary
The project is a multi-center, prospective cohort study. The study's total targeted enrollment is 400 first-episode patients with major depressive disorder (MDD) and 400 healthy controls.
Details
Lead Sponsor:
Peking University
Treatments:
Antidepressive Agents
Citalopram
Dexetimide
Duloxetine Hydrochloride
Lithium Carbonate
Mirtazapine